Related Experiment Video
Updated: May 30, 2026
06:05
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Mitochondrial DNA disease: new options for prevention
Lyndsey Craven1, Joanna L Elson, Laura Irving
1Mitochondrial Research Group and Newcastle University Centre for Brain Ageing and Vitality, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK.
Human Molecular Genetics
|August 20, 2011
Summary
Preventing mitochondrial DNA (mtDNA) disease transmission is now possible through pronuclear transfer techniques. Further research and legislative changes are needed for clinical application.
Area of Science:
- Genetics
- Reproductive Medicine
- Mitochondrial Biology
Background:
- Mitochondrial DNA (mtDNA) diseases are inherited maternally.
- Current treatments for mtDNA diseases are limited.
- Recent advancements offer potential for preventing mtDNA disease transmission.
Purpose of the Study:
- To discuss the clinical and scientific background of mtDNA disease prevention.
- To review essential research for establishing safety and efficacy of pronuclear transfer.
- To address potential concerns regarding the clinical application of these techniques.
Main Methods:
- Review of recent scientific literature on pronuclear transfer in human embryos and primate models.
- Discussion of clinical and legislative requirements for human application.
- Analysis of safety and efficacy considerations for mtDNA disease prevention.
Main Results:
- Intriguing data suggests pronuclear transfer can prevent mtDNA transmission.
- Techniques show promise but require further validation.
- Legislative amendments are necessary for clinical implementation in the UK.
Conclusions:
- Pronuclear transfer offers a potential strategy to prevent transmission of mitochondrial DNA diseases.
- Extensive research is crucial to ensure the safety and efficacy of these techniques before clinical use.
- Addressing ethical and legal considerations, including legislative changes, is essential for translational success.
Related Concept Videos
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:39Mitochondrial Precursor Proteins
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Most of the mitochondrial precursors...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...